Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2856 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Codexis and Arch Pharmalabs expand collaboration

Codexis will offer multiple pharmaceutical intermediates and active pharmaceutical ingredients (API) made with its proprietary biocatalytic processes to both innovator and generic drug manufacturers. Sales in India will

Rhei Pharmaceuticals names new CEO

Dr Cauwenbergh succeeds Joos Horsten, who recently passed away. Dr Cauwenbergh has been assisting Rhei Pharmaceuticals since August 1, 2008 in providing the necessary leadership to continue the

Anthill Technologies signs agreement with Zafgen

Under the agreement, Anthill will use its Acos high-speed synthesis and on-demand purification capabilities to assist Zafgen in the development of lead compounds for its obesity therapy programs.

MedRisk names new director of clinical services

In this role, Mr Clifton oversees and coordinates all clinical internal and external peer review activities and assists in product and network development. Most recently, Mr Clifton served

Proteostasis raises $45 million in series A financing

Investors included HealthCare Ventures, Fidelity Biosciences, New Enterprise Associates, Novartis Option Fund and Genzyme Ventures. Christopher Mirabelli, chairman of the board of Proteostasis, said: “The significant series A